Literature DB >> 20370694

Pharmacophore based drug design approach as a practical process in drug discovery.

Qingzhi Gao1, Lulu Yang, Yongqiang Zhu.   

Abstract

This review summarizes the background and updated progress of pharmacophore based drug design and provides the fundamental approach strategies on both structure based and ligand based pharmacophore approaches. The different programs and methodologies enable the implementation of more accurate and sophisticated pharmacophore model generation and application in drug discovery. This review will discuss and illustrate their advantages in pharmacophore based virtual screening and exemplify the detailed application workflow, which can be easily utilized by pharmaceutical bench work medicinal chemists. Pharmacophore based drug design process includes pharmacophore modeling and validation; pharmacophore based virtual screening, virtual hits profiling and lead identification. Strategies and proven methodologies for pharmacophore modeling are described including common feature and 3D QSAR based pharmacophore generation as well as structure based pharmacophore development. Different virtual screening strategies will be described in this review with detailed case studies for supporting practical applications. Representative success examples of pharmacophore based virtual screening for lead generation will be collected to demonstrate capabilities.

Mesh:

Substances:

Year:  2010        PMID: 20370694     DOI: 10.2174/157340910790980151

Source DB:  PubMed          Journal:  Curr Comput Aided Drug Des        ISSN: 1573-4099            Impact factor:   1.606


  18 in total

Review 1.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Software and resources for computational medicinal chemistry.

Authors:  Chenzhong Liao; Markus Sitzmann; Angelo Pugliese; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2011-06       Impact factor: 3.808

3.  Ultra-High-Throughput Structure-Based Virtual Screening for Small-Molecule Inhibitors of Protein-Protein Interactions.

Authors:  David K Johnson; John Karanicolas
Journal:  J Chem Inf Model       Date:  2016-01-14       Impact factor: 4.956

4.  Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation.

Authors:  Erica Gazzillo; Stefania Terracciano; Dafne Ruggiero; Marianna Potenza; Maria Giovanna Chini; Gianluigi Lauro; Katrin Fischer; Robert Klaus Hofstetter; Assunta Giordano; Oliver Werz; Ines Bruno; Giuseppe Bifulco
Journal:  Molecules       Date:  2022-06-16       Impact factor: 4.927

5.  Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.

Authors:  Sameera Senaweera; Haijuan Du; Huanchun Zhang; Karen A Kirby; Philip R Tedbury; Jiashu Xie; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Viruses       Date:  2021-04-27       Impact factor: 5.818

6.  Exploring DNA topoisomerase I ligand space in search of novel anticancer agents.

Authors:  Malgorzata N Drwal; Keli Agama; Laurence P G Wakelin; Yves Pommier; Renate Griffith
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

7.  Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.

Authors:  Samra Khalid; Rumeza Hanif; Ishrat Jabeen; Qaisar Mansoor; Muhammad Ismail
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

8.  An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs.

Authors:  Jie Xia; Hongwei Jin; Zhenming Liu; Liangren Zhang; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2014-05-01       Impact factor: 4.956

9.  Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase 2 inhibitors.

Authors:  Anna Vuorinen; Roger Engeli; Arne Meyer; Fabio Bachmann; Ulrich J Griesser; Daniela Schuster; Alex Odermatt
Journal:  J Med Chem       Date:  2014-07-10       Impact factor: 7.446

10.  Aromatic Rings Commonly Used in Medicinal Chemistry: Force Fields Comparison and Interactions With Water Toward the Design of New Chemical Entities.

Authors:  Marcelo D Polêto; Victor H Rusu; Bruno I Grisci; Marcio Dorn; Roberto D Lins; Hugo Verli
Journal:  Front Pharmacol       Date:  2018-04-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.